Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Shareholder vote
confidence 95%
filed 2026-07-01
Item 5.07
This is a clear disclosure of shareholder vote results from the Annual Meeting of Shareholders held on June 30, 2026. The filing reports the outcome of Proposal 1 regarding the selection of CM3 Advisory as the independent registered public accounting firm, with 12,308,780 votes for, 4,312 against, and 0 abstentions. This is a material governance matter affecting the registrant's auditor selection and is properly classified under Item 5.07.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-01
Item 3.02
The Company exchanged 1,830 shares of Series B Preferred Stock (aggregate stated value $1,830,000) for 11,000,786 shares of common stock in unregistered transactions under Section 3(a)(9) of the Securities Act, representing a significant equity dilution event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-01
Item 5.07
Annual meeting of stockholders held on June 30, 2026 approved all four proposals: election of five directors, ratification of CBIZ as independent auditor, approval of reverse stock split authority, and adjournment authority.
View raw filing on EDGAR →
6-K
Other material
confidence 72%
filed 2026-07-01
EX-99.1
The exhibit announces an ADS ratio change (1 ADS representing 60 Class A shares, effective as a 1-for-30 reverse ADS split) becoming effective July 6, 2026. This is a material capital structure event affecting all ADS holders' share counts and trading price, but it does not fit neatly into the taxonomy's specific event types—it is neither a dilutive issuance, dividend distribution, nor a governance action requiring shareholder approval. The event is clearly material to investors (affects trading mechanics and share count) but belongs in the financial domain without a precise category match.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02 discloses the appointment of Joshua Girnun to Nova Minerals' Board of Directors as a Class I director, effective July 1, 2026. The Board expanded from five to six directors to accommodate this appointment. The press release emphasizes Girnun's significant institutional finance and technical resource background from JP Morgan, positioning him as a key addition during the company's transition to production. This is a material governance event affecting board composition and strategic oversight.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-07-01
EX-99.1
The Board has approved exploration of a strategic AI, blockchain, and crypto-payment platform to digitalize the company's apparel supply-chain operations. While no capital has been committed yet, the announcement discloses a material strategic initiative with indicative investment of US$10–12 million over three years. This is an operational/strategic business event—a material contract or partnership milestone—that does not fit the specific event types (M&A, earnings, executive changes, etc.) but clearly affects investor assessment of the company's strategic direction and capital allocation plans.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-01
EX-99.1
This announcement discloses the commencement of processing operations at Almonty's Sangdong Mine in South Korea, marking the transition from development phase to active, revenue-generating operations. The company has begun feeding stockpiled ore through its newly commissioned processing plant to produce saleable tungsten concentrate. This is a material operational milestone for a mining company — the shift from capital-intensive development to production — with quantified inventory (139,700 tonnes at ~0.25% WO₃ grade) and an illustrative gross in-process value of approximately US$68 million. While not a discrete M&A event, workforce action, or financial obligation, this represents a significant operational and strategic advancement that would affect a reasonable investor's assessment of the company's near-term revenue generation and execution capability.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-07-01
NextBoat entered into a Strategic Partnership and Revenue Sharing Agreement with MarineMax on June 25, 2026, establishing MarineMax as its preferred wholesale partner for pre-owned vessel transactions. The agreement includes warrant issuance (1,250,000 shares at $3.25–$7.00 per share) and a five-year term, representing a material strategic transaction that will drive significant volume through NextBoat's AI platform. Item 1.01 explicitly discloses this as a "Material Definitive Agreement," and the press release emphasizes this as a "landmark strategic partnership" and "defining milestone" expected to accelerate growth across the marketplace, data, and financing businesses.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
The filing discloses the appointment of Chris Janis as a member of the Board of Directors, Chairperson of the Audit Committee, and member of the Compensation Committee on July 1, 2026. Item 5.02 explicitly covers this appointment, and the press release emphasizes his 35+ years of financial and governance expertise from PwC and prior CFO roles. This is a material governance event affecting board composition and oversight structure.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-07-01
The filing discloses settlement and extinguishment of $2.8 million in disputed accounts payable through two separate resolutions: (1) dismissal of B&I Contractors' crossclaims and satisfaction of a $1.1 million mechanics lien on the Miramar property, and (2) full payment of $1.2 million owed to EirGenix under a manufacturing settlement. These are financial obligations being resolved, affecting the company's balance sheet and cash position materially, but do not fit the specific categories of debt_issuance, covenant_breach, or other named financial events—making financial_other the most appropriate classification.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-01
The filing discloses completion of Beeline's acquisition of MagicBlocks, an AI company whose technology powers the company's proprietary AI agent "Bob." Beeline acquired the remaining interest in MagicBlocks by issuing 209,456 shares at $2.25 per share ($471,276 in consideration), bringing full ownership of a previously 48%-owned related-party investment. This is a material acquisition that strengthens Beeline's core AI infrastructure and is disclosed under Item 7.01 via press release (Exhibit 99.1).
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-07-01
The filing discloses the creation of a new direct financial obligation under Item 1.01 and Item 2.03: BranchOut Food Inc. borrowed an additional $1,000,000 from Kaufman Kapital LLC on June 30, 2026, increasing the total secured promissory note from $3,000,000 to $4,000,000. The note matures January 28, 2027, bears 8% interest, and is secured by substantially all company assets. This is a material debt issuance that would affect a reasonable investor's assessment of the company's capital structure and financial obligations.
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-07-01
Maja Vujinovic, Co-Founder and CEO of FG Nexus's Digital Assets Division, departed her employment and resigned from the Board effective June 30, 2026, in connection with the Company's strategic exit from the digital asset business. While the filing also discloses severance and consulting arrangements, the principal disclosed action is her departure from employment and board resignation, making this an executive departure event.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 85%
filed 2026-07-01
The filing discloses settlement of a Nevada state court action (Case No. A-21-840033-B) and related JAMS arbitration involving claims relating to an alleged 2021 NFT-related contract. The Company will pay $100,000 and surrender 2,000,000 restricted shares (representing its entire equity interest in MFAI) to resolve all claims. This is a material litigation settlement that would affect a reasonable investor's assessment of the registrant's legal and financial position.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-01
The filing discloses entry into an ATM (At-The-Market) Sales Agreement on June 30, 2026, under Item 1.01, authorizing the sale and issuance of $18.5 million in common stock shares through Bancroft Capital, LLC. This is a classic dilutive equity issuance that would materially affect existing shareholders through dilution and is a significant capital-raising event for the company.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-07-01
EX-99.1
PowerBank closed a registered direct offering of 7,000,000 common shares to institutional investors, raising U.S.$4.2 million. This is a dilutive equity issuance under an effective shelf registration statement (Form F-10), representing a material capital raise that increases share count and dilutes existing shareholders. The offering was made pursuant to a registered prospectus supplement, consistent with a registered direct offering structure.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 75%
filed 2026-07-01
Item 7.01
TON Strategy announced entry into a Rule 10b5-1 trading plan to repurchase common stock over a two-month period beginning July 1, 2026, under its existing $250 million stock repurchase authorization. While share repurchases are a form of capital return to shareholders (similar in economic effect to dividends), the disclosure focuses on the mechanics of the repurchase program and its execution rather than a declared distribution. The materiality is high given the $250 million authorization and potential shareholder value impact, though the event is more precisely a share-repurchase program announcement than a traditional dividend distribution.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-07-01
SurgePays amended its agreement with AT&T Mobility on June 29, 2026, eliminating $50 million in minimum spend commitments and securing $10.3 million in forgiveness of previously billed charges, resulting in an $8.5 million gain in Q2 2026. While this generates a material accounting benefit and improves operating margins, the core event is a material contract amendment with a key supplier—a strategic operational matter that does not fit the specific financial categories (debt issuance, impairment, etc.) but clearly affects the company's cost structure and financial performance.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-07-01
NextTrip disclosed the creation of new direct financial obligations under Item 1.01 and Item 2.03: short-term unsecured loans totaling $950,000 principal from The Donald P. Monaco Insurance Trust (a related party controlled by director Donald P. Monaco), bearing 7.5% simple interest and maturing July 15, 2026. This constitutes a debt issuance—creation of a new direct financial obligation—and is material given the substantial principal amount, related-party nature, and short maturity profile indicating potential liquidity stress.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-07-01
The filing discloses a declaration by the Board of Directors of a quarterly cash dividend of $0.15 per share on the Company's 6% Convertible Exchangeable Preferred Stock, payable on August 1, 2026. This is a clear dividend distribution event under Item 8.01 (Other Events), and dividend declarations are material to investors as they affect shareholder returns and capital allocation.
View raw filing on EDGAR →
6-K
M&A activity
confidence 85%
filed 2026-07-01
The 6-K discloses completion of a material acquisition: Genenta Science acquired majority equity ownership in Sòphia High Tech S.r.l. through a Share Purchase and Investment Agreement dated April 22, 2026, with closing completed following satisfaction of all conditions including Italian Golden Power authorization. This represents a change of control transaction material to investors.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-01
Onity Group closed the sale of its reverse mortgage servicing portfolio (approximately 20,000 loans with $5.2 billion unpaid principal balance) and reverse originations assets to Finance of America Reverse LLC, with net proceeds of $70–$80 million and a three-year subservicing arrangement. This is a material disposition of a significant business segment that repositions the company's role in the reverse mortgage market and affects its earnings profile and strategic direction.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 75%
filed 2026-07-01
The Company entered into a Second Amendment Agreement on June 25, 2026, to extend the maturity date of promissory notes from March 31, 2026 to September 30, 2026. While this is technically an amendment to existing debt rather than a new issuance, the extension of maturity on outstanding notes with accrued interest represents a material modification of a direct financial obligation. The involvement of the Chairman/CEO and major shareholders as purchasers, combined with the repeated extensions (original agreement September 2024, first amendment December 2025, second amendment June 2026), suggests ongoing refinancing activity that would be material to investors assessing the Company's liquidity and financial position.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-07-01
The 8-K discloses the Board of Directors' declaration of quarterly cash dividends on both common stock ($0.225 per share) and preferred stock ($0.3984375 per share), with payment dates and record dates specified. This is a routine but material dividend declaration typical of a REIT, directly matching the dividend_distribution event type.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-01
The filing discloses entry into a Placement Agent Agreement on June 30, 2026, for the sale of 35,555 units consisting of 71,110 shares of common stock and 35,555 warrants at $18.00 per unit, generating gross proceeds of $639,990. This is a registered direct offering of equity securities (shares and warrants) that dilutes existing shareholders. The transaction closed on June 30, 2026, and the securities were issued pursuant to an effective Form S-3 shelf registration statement.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-07-01
Item 1.01
Mama's Creations entered into an underwriting agreement for a registered public offering of 5,555,556 shares of common stock at $18.00 per share, generating approximately $100 million in gross proceeds ($94 million net, potentially $115 million with underwriter option). This material equity issuance will dilute existing shareholders and materially affect the company's capital structure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-01
The filing discloses Item 5.07 results from Intellinetics' June 25, 2026 Annual Meeting of Stockholders, reporting voting outcomes on six proposals: election of five directors, approval of amendments to the 2024 Equity Incentive Plan and 2023 Director Plan, say-on-pay advisory vote, say-on-frequency advisory vote, and ratification of GBQ Partners LLC as independent auditor. All proposals passed with substantial majorities, making this a clear shareholder vote results disclosure.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-07-01
EX-99.1
This exhibit is a press release announcing Locafy's financial results for the nine-month period ended March 31, 2026. The document explicitly states "Locafy Reports 31% Revenue Growth for the First Nine Months of Fiscal 2026" and provides detailed financial highlights including subscription revenue growth of 36%, operating expense reductions of 13%, and net loss improvement of 36%. The release includes consolidated financial statements (profit/loss, balance sheet, and cash flows) and management commentary from the CEO. This is a discrete earnings announcement, not a periodic financial report filing itself, and is material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-07-01
OneMedNet entered into a Standby Equity Purchase Agreement (SEPA) with Yorkville on July 1, 2026, granting the option to sell up to $25 million of Common Stock at 97% of market price. The agreement includes an Exchange Cap of 11,386,834 shares (19.99% of outstanding shares), representing a significant dilutive issuance arrangement. This is a classic PIPE-like structure requiring a resale registration statement, disclosed under Item 1.01 as a material definitive agreement.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-07-01
The filing discloses entry into a material definitive agreement forming a 50/50 joint venture (Time Complexity Appalachia, LLC) between Range Impact's subsidiary and Time Complexity WV to develop a power generation and data center facility at the Fola mine site in West Virginia. This is coupled with issuance of a warrant for 14.5 million shares to the joint venture partner, representing a significant capital commitment and strategic partnership. The transaction is disclosed under Item 1.01 (Entry into a Material Definitive Agreement) and Item 3.02 (Unregistered Sales of Equity Securities), and the press release emphasizes this as "an important milestone" in the company's strategy to transform industrial assets into AI infrastructure platforms.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-07-01
Item 8.01
Idaho Copper Corporation announced the pricing and completion of an underwritten public offering of common stock and warrants for approximately $18 million gross proceeds at $4.85 per share, with an underwriter option to purchase additional shares to cover over-allotments. This is a material equity issuance that raises capital and creates dilution to existing shareholders. While the filing also mentions NYSE American listing approval, the core material event disclosed in Item 8.01 is the public offering of equity securities.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02
X4 Pharmaceuticals appointed Kelly Gold as a Class II director effective July 1, 2026, increasing the board size from five to six directors. Ms. Gold, an experienced CFO with prior roles at Biogen and Deutsche Bank, was also appointed to the Audit Committee as an independent director.
View raw filing on EDGAR →
8-K
Earnings release
confidence 85%
filed 2026-07-01
Item 2.02
Athene disclosed preliminary estimates of alternative net investment income of $350 million pre-tax with a 9% annualized return for Q2 2026 as a Regulation FD disclosure prior to Apollo's full earnings release on August 4, 2026. This constitutes an early release of material quarterly financial results and key performance metrics.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-01
Item 5.02
The disclosure centers on compensatory arrangements for the CEO and named executive officers, including restricted stock awards, incentive stock options, and base salary increases approved by the Board on June 26, 2026. The filing explicitly states the awards were granted "in order to align the economic interests" of executives with the Company and stockholders, and details the specific equity grants (174,081 restricted shares and 26,041 options for CEO Abinand Rangesh) and salary increases (5% for Rangesh to $220,500; 3% for other NEOs). This is a classic exec_compensation disclosure under Item 5.02(e).
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-07-01
Item 8.01
The Company declared monthly distributions for June 2026 across eight classes of common stock, with net distributions per share ranging from $0.05831 to $0.07495, payable on July 2, 2026. This is a routine but material dividend declaration typical of real estate investment trusts (REITs), which are required to distribute substantially all taxable income to shareholders.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-01
Item 5.02
Jessica Mitory, Senior Vice President and Chief Human Resources Officer, provided notice of resignation effective August 17, 2026. This is a clear departure of a named executive officer. While the filing notes no disagreement with the Company, the departure of a C-suite executive responsible for human resources is material to investors' assessment of leadership continuity and organizational stability.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 85%
filed 2026-07-01
Item 8.01
News Corporation discloses daily share repurchase activity under its authorized $1 billion repurchase program, with specific transactions totaling approximately $342.5 million to date. Share repurchases are a form of capital return to shareholders and fall within the dividend_distribution category, which encompasses "share-repurchase programs." The filing reports actual buyback activity (8.76 million Class A shares and 76,679 Class B shares purchased on 01/07/2026 for ~$222 million combined), demonstrating active execution of the program.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-01
Item 5.07
Dell Technologies held its 2026 annual meeting on June 25, 2026, with shareholders voting on four proposals: election of eight directors, ratification of PricewaterhouseCoopers LLP as auditor, advisory vote on named executive officer compensation, and approval of redomestication from Delaware to Texas. All proposals passed with detailed vote tallies reported.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-07-01
Item 8.01
Dell Technologies completed its redomestication from a Delaware corporation to a Texas corporation, effective July 1, 2026, following stockholder approval at the June 2026 annual meeting. The redomestication resulted in material modifications to shareholder rights, including changes to derivative proceeding thresholds under Texas law versus Delaware law.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-01
Item 1.01
Kimball Electronics completed the acquisition of Helvoet Polymer Technologies B.V. and related entities for approximately €90 million ($103 million) on June 26–July 1, 2026. The transaction expands Kimball's medical CDMO platform globally and is expected to be accretive to fiscal 2027 adjusted earnings.
View raw filing on EDGAR →
6-K
M&A activity
confidence 98%
filed 2026-07-01
EX-99.1
Suzano completed the acquisition of a 51% equity interest in FamPro Tissue Holdings B.V. (Arbex) from Kimberly-Clark Corporation for USD 1.3 billion on July 1, 2026. The disclosure explicitly states the transaction has been "completed" with "satisfaction of all conditions precedent and the consummation of the closing acts," establishing this as a material acquisition event that would significantly affect investor assessment of the company's capital deployment and strategic direction.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-01
Item 2.02
General Mills issued a press release on July 1, 2026 reporting financial results for its quarter and fiscal year ended May 31, 2026. The disclosure includes detailed quarterly and full-year results covering net sales, operating profit, diluted EPS, segment performance, and forward guidance. This is a standard earnings release disclosing quarterly and annual financial results, which is material to investors assessing the company's financial performance and outlook.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-01
Item 2.02
FactSet disclosed its third quarter fiscal 2026 financial results via press release on July 1, 2026, reporting GAAP revenues of $622.9 million (up 6.4% YoY), organic ASV growth of 7.1%, and adjusted diluted EPS of $4.53 (up 6.1% YoY). The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the earnings release furnished as Exhibit 99.1, which is the standard format for quarterly earnings disclosures.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-07-01
Item 8.01
Precision Biosciences announced clinical trial progress for two gene-therapy programs: PBGENE-HBV demonstrated cccDNA elimination in the ELIMINATE-B study with a 1-log reduction in transcripts, and a second clinical site was activated at Washington University for the FUNCTION-DMD trial in Duchenne muscular dystrophy.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 95%
filed 2026-07-01
ECARX Holdings' subsidiary ECARX Ecological entered into a syndicated loan agreement on June 29, 2026, for RMB 1,260,000,000 (approximately US$185 million) to finance the acquisition of Hubei Qiguang Technology Co., Ltd. This is a creation of a new direct financial obligation with a 10-year term, repayable in semi-annual installments beginning December 2026, secured by pledge of the acquired company's equity interests and a guarantee from Hubei Qiguang. The materiality and size of the debt facility, combined with its use to fund a previously announced acquisition, makes this a material debt issuance event.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-07-01
The 6-K discloses the complete voting results from Super Group's June 25, 2026 Annual Meeting of Shareholders, including approval of the annual report and audited financial statements, ratification of Deloitte LLP as auditor, re-appointment of six directors (Eric Grubman, Robert James Dutnall, John Le Poidevin, Natara Holloway Branch, Jonathan Jossel, and Merrick Wolman), and authorization for share repurchases up to 14.99% of outstanding shares. This is a standard shareholder_vote_results disclosure under Item 5.07 equivalent, and the outcomes are material to investors as they confirm board composition and capital allocation authority.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-01
Item 2.02
UniFirst issued a press release on July 1, 2026 announcing financial results for the third quarter of fiscal 2026 ended May 30, 2026. The disclosure includes consolidated revenues of $634.4 million, operating income of $23.0 million, net income of $19.9 million, and diluted EPS of $1.09, along with detailed segment reporting and balance sheet information. This is a standard quarterly earnings release attached as Exhibit 99 to the 8-K filing under Item 2.02.
View raw filing on EDGAR →
8-K
Governance Other
confidence 77%
filed 2026-07-01
Item 5.03
Alight stockholders approved on June 10, 2026 three governance amendments: declassification of the Board, extension of officer exculpatory protection under Delaware law, and a 1-for-20 reverse stock split with corresponding authorized share reductions. The reverse stock split became effective on July 1, 2026, with Class A common stock beginning to trade on a split-adjusted basis on the NYSE under ticker 'ALIT' with a new CUSIP number.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-01
Item 8.01
The filing announces the completion of PPHC's acquisition of Tancredi Intelligent Communication Ltd on July 1, 2026. The press release details the transaction structure (initial consideration of £8.0 million in cash and equity, plus contingent earnout payments up to £25 million maximum), strategic rationale, and integration into TrailRunner International. This is a material acquisition event requiring disclosure under Item 8.01 (Other Events) as a completed M&A transaction.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-01
Item 8.01
Cycurion entered into an Asset Purchase Agreement on June 24, 2026, to acquire substantially all assets of Kustom Entertainment's video-solutions division (the "Business"), including Digital Ally-branded video systems, body-worn cameras, and digital evidence management solutions. The transaction includes $1.25 million cash, a $4.25 million secured promissory note, up to $1.0 million earnout, and warrants for 2 million shares, with closing expected in early July 2026. This is a material acquisition that expands Cycurion's product portfolio and customer base by approximately 1,000 clients and adds ~$5.1 million in annual revenue and ~$8.0 million in backlog.
View raw filing on EDGAR →